Detecting cancer early can save lives. When cancer is found at an early stage, treatment is often more effective and outcomes are much better.
However, many cancers are still discovered late because early signs can be weak or easy to miss. Doctors often rely on scans or invasive procedures, which can be expensive, uncomfortable, and not always suitable for regular screening.
Now, a new study offers hope for a simpler and less invasive way to detect and monitor cancer.
Researchers from Weill Cornell Medicine and the New York Genome Center have developed a new method that may allow doctors to use a simple blood test to find cancer and track how it changes over time. The study was published in the journal Nature Methods on April 11.
This new method focuses on something called circulating tumor DNA, or ctDNA. When cancer cells grow and divide, they release small pieces of their DNA into the bloodstream. These tiny fragments carry information about the cancer. By finding and measuring this DNA, doctors can learn whether cancer is present and how it is behaving.
The challenge is that ctDNA is usually found in very small amounts, especially in early-stage cancer. It can be extremely difficult to detect because it is mixed with a large amount of normal DNA in the blood. In some cases, tumor DNA may make up only one part in a million.
To solve this problem, the research team developed a more powerful way to read DNA. They used a technique called whole-genome sequencing, which looks at all of a person’s DNA instead of focusing on just a few areas. This gives a much more complete picture and increases the chance of finding small traces of cancer DNA.
In the past, this type of deep sequencing was too expensive for routine use. However, the team used a new, lower-cost sequencing platform developed by Ultima Genomics. This technology allows scientists to read DNA more deeply while keeping costs down, making it more practical for wider use in the future.
Another important improvement in this study was the use of a special error-checking method. DNA is made up of two strands that mirror each other. By comparing both strands, the researchers were able to identify and remove mistakes that can happen during sequencing. This made the test much more accurate and reliable.
The researchers tested their method on patients with bladder cancer and melanoma. They were able to detect cancer using only blood samples. Even more importantly, they could track changes in ctDNA levels over time.
When cancer got worse or came back, the levels of ctDNA in the blood increased. When patients responded well to treatment, the levels went down. This means the test could be used not only to detect cancer, but also to monitor how well treatment is working and to check for signs of recurrence.
Dr. Dan Landau, the senior author of the study and an oncologist at NewYork-Presbyterian/Weill Cornell Medical Center, said that this new approach is a major step forward. He explained that improvements in technology and lower costs are bringing us closer to a future where blood tests can be used regularly to manage cancer.
Dr. Bishoy Faltas, another researcher involved in the study, added that using the unique DNA patterns of each person’s cancer helped make the test even more sensitive. This personalized approach allows doctors to detect even the smallest traces of cancer.
Although more research and clinical trials are needed, the findings are very promising. In the future, this method could lead to simple blood tests that help doctors detect cancer earlier, monitor its progress, and guide treatment decisions without the need for invasive procedures.
This could make cancer care more comfortable, more accurate, and more accessible for patients. It may also allow doctors to act more quickly when cancer changes, improving outcomes and saving lives.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and berry that can prevent cancer, diabetes, and obesity.
For more health information, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing vitamin D supplements could strongly reduce cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
